The role of transcatheter mitral valve leaflet approximation for the treatment of secondary mitral regurgitation: current status and future prospects

References

• Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015 Mar 31;65(12):1231–1248.
   PubMed Web of Science ®Google Scholar
• Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011 Sep 27;58(14):1474–1481.
   PubMed Web of Science ®Google Scholar
• Sannino A, Smith RL 2nd, Schiattarella GG, et al. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol. 2017 Oct 1;2(10):1130–1139.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129–2200.
   PubMed Web of Science ®Google Scholar
• Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007 Jun 5;49(22):2191–2201.
   PubMed Web of Science ®Google Scholar
• Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005 Feb 1;45(3):381–387.
   PubMed Web of Science ®Google Scholar
• Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016 May 19;374(20):1932–1941.
   PubMed Web of Science ®Google Scholar
• Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018 Dec 13;379(24):2297–2306.
   PubMed Web of Science ®Google Scholar
• Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018 Dec 13;379(24):2307–2318.
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006 Sep 16;368(9540):1005–1011.
   PubMed Web of Science ®Google Scholar
• Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the framingham heart study). Am J Cardiol. 1999 Mar 15;83(6):897–902.
   PubMed Web of Science ®Google Scholar
• Dziadzko V, Dziadzko M, Medina-Inojosa JR, et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J. 2019 Jul 14;40(27):2194–2202.
   PubMed Web of Science ®Google Scholar
• Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014 Jan 21;63(2):185–186.
   PubMed Web of Science ®Google Scholar
• Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007 Jun;28(11):1358–1365.
   PubMed Web of Science ®Google Scholar
• Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the Euro bservational research programme valvular heart disease II survey. Circulation. 2019 Sep 12;140(14):1156–1169.
   PubMed Web of Science ®Google Scholar
• Junker A, Thayssen P, Nielsen B, et al. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology. 1993;83(1–2):14–20.
   PubMed Web of Science ®Google Scholar
• Nagatsu M, Zile MR, Tsutsui H, et al. Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function. Circulation. 1994 Feb;89(2):818–826.
   PubMed Web of Science ®Google Scholar
• Masson S, Gorini M, Salio M, et al. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF investigators. Ital Heart J. 2000 Apr;1(4):282–288.
   PubMedGoogle Scholar
• Nishimura RA, Vahanian A, Eleid MF, et al. Mitral valve disease–current management and future challenges. Lancet. 2016 Mar 26;387(10025):1324–1334.
   PubMed Web of Science ®Google Scholar
• Bertrand PB, Schwammenthal E, Levine RA, et al. Exercise dynamics in secondary mitral regurgitation: pathophysiology and therapeutic implications. Circulation. 2017 Jan 17;135(3):297–314.
   PubMed Web of Science ®Google Scholar
• Chaput M, Handschumacher MD, Tournoux F, et al. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation. 2008 Aug 19;118(8):845–852.
   PubMed Web of Science ®Google Scholar
• Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005 Aug 2;112(5):745–758.
   PubMed Web of Science ®Google Scholar
• Varadarajan P, Sharma S, Heywood JT, et al. High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography. J Am Soc Echocardiography. 2006 Dec;19(12):1458–1461.
   PubMed Web of Science ®Google Scholar
• Bartko PE, Pavo N, Perez-Serradilla A, et al. Evolution of secondary mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):622–629.
   PubMed Web of Science ®Google Scholar
• Liang JJ, Silvestry FE. Mechanistic insights into mitral regurgitation due to atrial fibrillation: “Atrial functional mitral regurgitation”. Trends Cardiovasc Med. 2016 Nov;26(8):681–689.
   PubMed Web of Science ®Google Scholar
• Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol. 2019 May 21;73(19):2465–2476.
   PubMed Web of Science ®Google Scholar
• Kim DH, Heo R, Handschumacher MD, et al. Mitral valve adaptation to isolated annular dilation: insights into the mechanism of atrial functional mitral regurgitation. JACC Cardiovasc Imaging. 2019 Apr;12(4):665–677.
   PubMed Web of Science ®Google Scholar
• Ali M, Shreenivas SS, Pratt DN, et al. Percutaneous interventions for secondary mitral regurgitation. Circ Cardiovasc Interv. 2020 Aug;13(8):e008998.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Troisfontaines P, Toussaint AC, et al. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation. 2003 Oct 7;108(14):1713–1717.
   PubMed Web of Science ®Google Scholar
• Blanke P, Dvir D, Cheung A, et al. Mitral annular evaluation with CT in the context of transcatheter mitral valve replacement. JACC Cardiovasc Imaging. 2015 May;8(5):612–615.
   PubMed Web of Science ®Google Scholar
• Garg P, Swift AJ, Zhong L, et al. Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging. Nat Rev Cardiol. 2020 May;17(5):298–312.
   PubMed Web of Science ®Google Scholar
• Cavalcante JL, Kusunose K, Obuchowski NA, et al. Prognostic impact of ischemic mitral regurgitation severity and myocardial infarct quantification by cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2020 Jul;13(7):1489-1501.
   Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol. 2017 Aug 8;70(6):776–803.
   PubMed Web of Science ®Google Scholar
• Doughty RN, Whalley GA, Walsh HA, et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN echo substudy. Circulation. 2004 Jan 20;109(2):201–206.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Skali H, Anavekar NS, et al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005 Jun 28;111(25):3411–3419.
   PubMed Web of Science ®Google Scholar
• Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the heart failure association of the European society of cardiology. Eur J Heart Fail. 2019 May 26;21(10):1169–1186.
   Web of Science ®Google Scholar
• Nasser R, Van Assche L, Vorlat A, et al. Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction. JACC Heart Fail. 2017 Sep;5(9):652–659.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11;371(11):993–1004.
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SJ, Shin SH, et al. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation. 2019 Mar 12;139(11):1354–1365.
   PubMed Web of Science ®Google Scholar
• Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J. 2016 Mar 07;37(10):817–825.
   PubMed Web of Science ®Google Scholar
• Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999 Apr 15;83(8):1201–1205.
   PubMed Web of Science ®Google Scholar
• Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail. 2019 Sep 7;7(11):945–955.
   PubMed Web of Science ®Google Scholar
• Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001 Sep 18;104(12 Suppl 1):I68–75.
   PubMed Web of Science ®Google Scholar
• Campwala SZ, Bansal RC, Wang N, et al. Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery. Eur J Cardio-thorac Surg. 2005 Nov;28(5):783–787.
   PubMed Web of Science ®Google Scholar
• Palardy M, Stevenson LW, Tasissa G, et al. Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial. Circ Heart Fail. 2009 May;2(3):181–188.
   PubMed Web of Science ®Google Scholar
• Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019 Jan 5;393(10166):31–39.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Pratley R, Dagogo-Jack S, et al. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med. 2020 Oct 8;383(15):1425–1435.
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001 Mar 22;344(12):873–880.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005 Apr 14;352(15):1539–1549.
   PubMed Web of Science ®Google Scholar
• St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003 Apr 22;107(15):1985–1990.
   PubMed Web of Science ®Google Scholar
• Di Biase L, Auricchio A, Mohanty P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace. 2011 Jun;13(6):829–838.
   PubMed Web of Science ®Google Scholar
• Spartera M, Galderisi M, Mele D, et al. Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2016 May;17(5):471–480.
   PubMed Web of Science ®Google Scholar
• Van Bommel RJ, Marsan NA, Delgado V, et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation. 2011 Aug 23;124(8):912–919.
   PubMed Web of Science ®Google Scholar
• Trichon BH, Glower DD, Shaw LK, et al. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. Circulation. 2003 Sep 9;108(Suppl 1):II103–10.
   PubMedGoogle Scholar
• Castleberry AW, Williams JB, Daneshmand MA, et al. Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. Circulation. 2014 Jun 17;129(24):2547–2556.
   PubMed Web of Science ®Google Scholar
• Samad Z, Shaw LK, Phelan M, et al. Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. Eur Heart J. 2015 Oct 21;36(40):2733–2741.
   PubMed Web of Science ®Google Scholar
• Yousefzai R, Bajaj N, Krishnaswamy A, et al. Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol. 2014 Oct 1;114(7):1011–1017.
   PubMed Web of Science ®Google Scholar
• Goyal P, Kim J, Feher A, et al. Myocardial perfusion pattern for stratification of ischemic mitral regurgitation response to percutaneous coronary intervention. Coron Artery Dis. 2015 Dec;26(8):642–650. .
   PubMed Web of Science ®Google Scholar
• Petrus AHJ, Dekkers OM, Tops LF, et al. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes. Eur Heart J. 2019 Jul 14;40(27):2206–2214.
   PubMed Web of Science ®Google Scholar
• Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016 Jan 28;374(4):344–353.
   PubMed Web of Science ®Google Scholar
• Harmel EK, Reichenspurner H, Girdauskas E. Subannular reconstruction in secondary mitral regurgitation: a meta-analysis. Heart. 2018 Nov;104(21):1783–1790.
   PubMed Web of Science ®Google Scholar
• Chancellor WZ, Schubert SA, Ailawadi G. Transcatheter interventions for functional mitral regurgitation. Ann Cardiothorac Surg. 2018 Nov;7(6):764–770.
   PubMed Web of Science ®Google Scholar
• Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardio-thorac Surg. 1998 Mar;13(3):240–245. discussion 245-6.
   PubMed Web of Science ®Google Scholar
• De Bonis M, Lapenna E, Barili F, et al. Long-term results of mitral repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: does the technique matter? Eur J Cardio-thorac Surg. 2016 Nov;50(5):882–889.
   PubMed Web of Science ®Google Scholar
• Corpataux N, Winkel MG, Kassar M, et al. The PASCAL device-early experience with a leaflet approximation device: what are the benefits/limitations compared with the MitraClip? Curr Cardiol Rep. 2020 Jun 27;22(8):74.
   PubMed Web of Science ®Google Scholar
• Condado JA, Acquatella H, Rodriguez L, et al. Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case. Catheter Cardiovasc Interv. 2006 Feb;67(2):323–325.
   PubMed Web of Science ®Google Scholar
• Franzen O, Van Der Heyden J, Baldus S, et al. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011 May;13(5):569–576.
   PubMed Web of Science ®Google Scholar
• Nickenig G, Estevez-Loureiro R, Franzen O, et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 pilot European sentinel registry. J Am Coll Cardiol. 2014 Sep 2;64(9):875–884.
   PubMed Web of Science ®Google Scholar
• Neuss M, Schau T, Schoepp M, et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail. 2013 Jul;15(7):786–795.
   PubMed Web of Science ®Google Scholar
• Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol. 2011 Nov 15;58(21):2183–2189.
   PubMed Web of Science ®Google Scholar
• Giannini C, Fiorelli F, De Carlo M, et al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol. 2016 Jan 15;117(2):271–277.
   PubMed Web of Science ®Google Scholar
• Swaans MJ, Bakker AL, Alipour A, et al. Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC Cardiovasc Interventions. 2014 Aug;7(8):875–881.
   PubMed Web of Science ®Google Scholar
• Velazquez EJ, Samad Z, Al-Khalidi HR, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J. 2015 Nov;170(5):1050–1059 e3.
   PubMed Web of Science ®Google Scholar
• Praz F, Winkel MG, Fam NP, et al. Age for transcatheter mitral valve repair: the complexity of choice. JACC Cardiovasc Interventions. 2020 Oct 26;13(20):2415–2417.
   PubMed Web of Science ®Google Scholar
• Ben-Shoshan J, Overtchook P, Buithieu J, et al. Predictors of outcomes following transcatheter edge-to-edge mitral valve repair. JACC Cardiovasc Interventions. 2020 Aug 10;13(15):1733–1748.
   PubMed Web of Science ®Google Scholar
• Praz F, Braun D, Unterhuber M, et al. Edge-to-edge mitral valve repair with extended clip arms: early experience from a multicenter observational study. JACC Cardiovasc Interventions. 2019 Jul 22;12(14):1356–1365.
   PubMed Web of Science ®Google Scholar
• Chakravarty T, Makar M, Patel D, et al. Transcatheter edge-to-edge mitral valve repair with the MitraClip G4 system. JACC Cardiovasc Interv. 2020 Oct 26;13(20):2402–2414.
   PubMed Web of Science ®Google Scholar
• Jörg H Contemporary, real-world clinical outcomes with the next-generation MitraClip (NTR/XTR) system in patients with secondary mitral regurgitation: results from the global EXPAND Registry. Presented at: PCR Valves; 2020. Nov 23. London, England.
   Google Scholar
• Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017 Aug 19;390(10096):773–780.
   PubMed Web of Science ®Google Scholar
• Webb JG, Hensey M, Szerlip M, et al. 1-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. JACC Cardiovasc Interv. 2020 Oct 26;13(20):2344–2357.
   PubMed Web of Science ®Google Scholar
• Iung B, Armoiry X, Vahanian A, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years. Eur J Heart Fail. 2019 Dec;21(12):1619–1627.
   PubMed Web of Science ®Google Scholar
• Giustino G, Lindenfeld J, Abraham WT, et al. NYHA functional classification and outcomes after transcatheter mitral valve repair in heart failure: the COAPT trial. JACC Cardiovasc Interventions. 2020 Oct 26;13(20):2317–2328.
   PubMed Web of Science ®Google Scholar
• Malik UI, Ambrosy AP, Ku IA, et al. Baseline functional capacity and transcatheter mitral valve repair in heart failure with secondary mitral regurgitation. JACC Cardiovasc Interventions. 2020 Oct 26;13(20):2331–2341.
   PubMed Web of Science ®Google Scholar
• Kosmidou I, Lindenfeld J, Abraham WT, et al. Transcatheter mitral valve repair in patients with and without cardiac resynchronization therapy: the COAPT trial. Circ Heart Fail. 2020 Nov;13(11):e007293.
   PubMed Web of Science ®Google Scholar
• Praz F, Grasso C, Taramasso M, et al. Mitral regurgitation in heart failure: time for a rethink. Eur Heart J. 2019 Jul 14;40(27):2189–2193.
   PubMed Web of Science ®Google Scholar
• Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiography. 2003 Jul;16(7):777–802. .
   PubMed Web of Science ®Google Scholar
• Vahanian A, Alfieri O, Andreotti F, et al. [Guidelines on the management of valvular heart disease (version 2012). The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome). 2013 Mar;14(3):167–214.
   PubMedGoogle Scholar
• Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362.
   Google Scholar
• Brugger N, Seiler C. Proportionality of functional mitral regurgitation: questioning the model’s fundamentals and its applicability in clinical practice. JACC Cardiovasc Imaging. 2020 Jun;13(6):1456–1457.
   PubMed Web of Science ®Google Scholar
• Adamo M, Cani DS, Gavazzoni M, et al. Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair. EuroIntervention. 2020 Aug 28;16(5):413–420.
   PubMed Web of Science ®Google Scholar
• Grayburn PA, Sannino A, Cohen DJ, et al. Predictors of clinical response to transcatheter reduction of secondary mitral regurgitation: the COAPT trial. J Am Coll Cardiol. 2020 Sep 1;76(9):1007–1014.
   PubMed Web of Science ®Google Scholar
• Iliadis C, Metze C, Korber MI, et al. Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair. Int J Cardiol. 2020 Oct;1(316):189–194.
   Google Scholar
• Ailawadi G, Lim DS, Mack MJ, et al. One-year outcomes after MitraClip for functional mitral regurgitation. Circulation. 2019 Jan 2;139(1):37–47.
   PubMed Web of Science ®Google Scholar
• Orban M, Karam N, Lubos E, et al. Impact of proportionality of secondary mitral regurgitation on outcome after transcatheter mitral valve repair. JACC Cardiovasc Imaging. 2020 Aug 24. DOI:10.1016/j.jcmg.2020.05.042.
   PubMedGoogle Scholar
• Estevez-Loureiro R, Adamo M, Arzamendi D, et al. Transcatheter mitral valve repair in patients with acute myocardial infarction: insights from the European registry of MitraClip in acute mitral regurgitation following an acute myocardial infarction (EREMMI). EuroIntervention. 2020 Feb 20;15(14):1248–1250.
   PubMed Web of Science ®Google Scholar
• Jung RG, Simard T, Kovach C, et al. Transcatheter mitral valve repair in cardiogenic shock and mitral regurgitation: a patient-level, multicenter analysis. JACC Cardiovasc Interventions. 2020 Oct 11;14:1–11.
   PubMedGoogle Scholar
• Godino C, Munafo A, Scotti A, et al. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge registry. J Heart Lung Transplant. 2020 Sep 17;39(12):1353–1362.
   PubMed Web of Science ®Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72–e227.
   PubMed Web of Science ®Google Scholar